EQL Pharma
EQL Pharma AB is a Swedish pharmaceutical company specializing in the development and distribution of generic and niche prescription medicines. The company develops, licenses, and markets generic pharmaceuticals with a primary focus on niche prescription drugs for hospital and retail pharmacy supply. Revenue is generated from the sale of prescription pharmaceuticals directly to pharmacy chains, healthcare regions, and pharmaceutical wholesalers. Core end markets encompass public healthcare authorities, hospitals, and retail consumers across the Nordic region and select European markets. EQL Pharma holds an established position in the Nordic generic pharmaceutical sector through its focus on niche prescription treatments with limited market competition. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
7 of the funds FundTelligence covers report a position in EQL Pharma.
- Legal name
- EQL Pharma AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 7
Funds holding EQL Pharma
- Aktie-Ansvar Räntestrategi — Aktie-Ansvar · 1.32 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 0.49 % (full portfolio disclosed, June 2026)
- IKC Avkastningsfond — IKC Capital · 0.22 % (full portfolio disclosed, June 2026)
- IKC Strategifond — IKC Capital · 0.22 % (full portfolio disclosed, June 2026)
- Storebrand Sverige Småbolag Plus — Storebrand · 0.02 % (full portfolio disclosed, October 2026)
- Handelsbanken Norden Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.01 % (full portfolio disclosed, October 2026)